Assistant Professor @ Institute of Pharmacology, @MedUni_Wien, former postdoc @UCSD
Joined February 2019
- Tweets252
- Following379
- Followers273
- Likes2K
Thomas Steinkellner retweeted
Our lab has an open postdoctoral position. Work in the lab ranges from trafficking of neuronal cargoes to developing gene editing therapeutics for Alzheimer's and Parkinson's. I'm looking for the right person, project is flexible. Please apply immediately.
roylab.org
Thomas Steinkellner retweeted
Dear all, we have a PhD position in lung cancer research.
Apply here!
euraxess.ec.europa.eu/jobs/3…
Please, RT.
#PhDposition
Thomas Steinkellner retweeted
We have a new Faculty position available in our Dept. Please share and repost. jobs.utoronto.ca/job/Toronto…
Thomas Steinkellner retweeted
We are hiring a new PhD student!
Join us in our quest to decipher the neurogenetic basis of #aggression using #zebrafish @MedUniGraz 🇦🇹
Project and program infos here:
medunigraz.at/doktoratsstudi…
DM me if interested, Please RT
Thomas Steinkellner retweeted
We are looking for a motivated postdoc to join our team studying the addictive process and circuitry! Please re-tweet or reach out with prospective candidates! #neuroscience #addiction neurojobs.sfn.org/job/38523/…
Thomas Steinkellner retweeted
Please RT
new postdoc position available in the lab
explore.jobs.ufl.edu/en-us/j…
Thomas Steinkellner retweeted
Reminder that CU Boulder is hiring three tenure track neuroscientists, broadly defined. Info/application here jobs.colorado.edu/jobs/JobDe…
Thomas Steinkellner retweeted
FDA approves first schizophrenia drug with a new mechanism of action since the 1950s tinyurl.com/34ceshw4
Karuna/Bristol Myers Squibb’s KarXT (Cobenfy), which acts on M1/M4 muscarinic acetylcholine receptors, expands the treatment landscape beyond dopamine-targeted drugs
Thomas Steinkellner retweeted
#Carcinogenic or not❓
All chemicals in use must undergo rigorous toxicological testing before they are approved. The postgraduate course in toxicology at @cancerCCR at #MedUniVienna starts in November with a new curriculum. Read more! ➡ bit.ly/3LU31z6
@CCCVienna
ALT Postgraduate Course: Toxicology
Thomas Steinkellner retweeted
Deadline has been extended to June 16th 2024…Get involved in the program of our wonderful #Vienna2025 ISSR meeting…Apply..Apply…👇👇👇 #5HT serotoninclub.org/
Submit Here: form.jotform.com/24041800931…
"A Serotonin Symphony in Vienna"
Call for Symposium Proposals Now OPEN!
Closes June 1, 2024....Do not miss this opportunity to get involved in our 2025 program!!!👇👇👇
form.jotform.com/24041800931…
More info @ serotoninclub.org/
Thomas Steinkellner retweeted
Ventral tegmental area interneurons revisited: GABA and glutamate projection neurons make local synapses biorxiv.org/cgi/content/shor… #biorxiv_neursci
Thomas Steinkellner retweeted
We're still recruiting research assistants, please get in touch if interested
Root lab is recruiting four research assistants to aid in stress-related research (jobs.colorado.edu/jobs/JobDe…) and ongoing projects (jobs.colorado.edu/jobs/JobDe…). Boulder is a great place to be, reach out if have questions!
Thomas Steinkellner retweeted
We're hiring! If you're interested in pharmacology and cancer metabolism, please check out this opportunity to join our lovely team as a research technician: nature.com/naturecareers/job…
Thomas Steinkellner retweeted
Finalized @eLife - collab w/ @DanielGitler, co-1st @SashaStavsky & @leonardoaparrar
To understand alpha-synuclein, you need to know who it lives and works with. We found a-syn must bind to a tiny (49 aa) domain in synapsin to influence synaptic activity: elifesciences.org/articles/8…
Thomas Steinkellner retweeted
Please RT: we have a job opening for a PhD student (4 years) studying alcohol use disorder in beautiful Vienna.
jobs.univie.ac.at/job/Univer…
Thomas Steinkellner retweeted
Looking forward to hearing from colleagues why reduced alpha synuclein is not pathogenic to the brain and why synuclein replacement has been dismissed without being tested and why a proposed biological definition of PD is premature
@beckerbarroso @pash22 @AlbertoEspay
Profs. @AlbertoEspay and @ajlees review the history of alpha-synuclein research and Parkinson’s disease to discuss myths and therapeutic implications in @ParkinsonismD
prd-journal.com/article/S135…
Thomas Steinkellner retweeted
The Membrane Transport Proteins GRC/GRS is fast approaching! We have a great line-up of speakers with extra slots available for late-breaking topics and short talks selected from abstracts. Submit your abstract by April 30 for consideration (1/4) grc.org/membrane-transport-p…
Thomas Steinkellner retweeted
This is huge news!
